New and updated assays increase application areas and improve performance MINNEAPOLIS — Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays. The developments increase both access to, and use of, RNAscope and improve overall robustness and ease-of-use. The continued investment in […]
Location: Cambridge Horizon’s Glutamine Synthetase-Knockout CHO K1 cell line has been used as part of a successful Investigational New Drug filing with the FDA Filing further validates the use of Horizon’s Bioproduction cell line platform for the manufacture of biotherapeutics Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader […]
FARMINGDALE, N.Y. – EpiGentek, a NY-based biotechnology firm specializing in epigenetic research products and services, announced its technological and financial support for new skincare startup EpigenCare. William Lee, who served as an operations executive for a number of years at EpiGentek, spearheads EpigenCare’s venture as its CEO. EpiGentek will work in collaboration with EpigenCare to […]
Lawrence, MA — Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, announced today that it has received a strategic investment from Ampersand Capital Partners. The funding will be primarily used to support Nexcelom’s worldwide growth initiatives. Founded in 2003, Nexcelom is a fast-growing supplier of innovative […]
MINNEAPOLIS — Bio-Techne has released MimEX™ GI, a new product line for generating 3-dimensional (3-D) gastrointestinal tissue on a 2-D surface. 3-D cell culture and organoid models of the gastrointestinal epithelium are quickly being adopted for toxicology, drug discovery, and disease modeling. These more complex models provide a tremendous benefit over cell line- and primary cell-based methods […]
Ortenberg, Germany – Cell-based assays have become an important application in the life science sector, from basic to top-level research. They are widely used in biotech companies and academic research institutions to monitor cell health in real-time. As experiments with living cells require constant physiological conditions, a precise gas control is essential. Our latest Atmospheric Control […]
SYDNEY, AUSTRALIA / Medical clinic and research facility Olympus Stem Cells Pty Ltd, based in Sydney Olympic Park, NSW, Australia, are pleased to announce the validation of 100% medical stem cell viability confirmed with Muse cell analyzer technology as described by Millipore Merck. More details can be obtained from https://www.olympusstemcells.com.au or https://www.merckmillipore.com. The Director of Olympus Stem Cells, […]
VANCOUVER, BRITISH COLUMBIA – STEMCELL Technologies has signed an exclusive license with Indiana University Innovation and Commercialization Office for patented rights to groundbreaking inner ear organoid technologies. The inner ear contains organs responsible for detecting sounds and maintaining balance, both of which are mediated by a sensory cell called the hair cell due to its specialized protrusions resembling tiny […]
Houston, TX and Emeryville, CA – The University of Texas MD Anderson Cancer Center and Berkeley Lights, Inc. today announced the launch of Optera Therapeutics Corp, a biopharmaceutical company developing cell therapies with scalable manufacturing solutions for cancer. Cell-based immunotherapies where patients are treated with their own immune cells, such as chimeric antigen receptor (CAR-T) and […]
AMSBIO reports on ground breaking research** by the Institute for Research in Biomedicine (IRB), Barcelona that cites use of its proprietary 3D organoid technology to develop a mouse model that mimics advanced human colon cancer. This model has allowed them to study the immune system response for the first time. In a short space of […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
